ZFYVE19
protein-codingzinc finger FYVE-type containing 19, the group of Zinc fingers FYVE-type
Gene summary
Enables phosphatidylinositol-3-phosphate binding activity. Involved in midbody abscission; mitotic cytokinesis checkpoint signaling; and negative regulation of cytokinesis. Located in centrosome; cleavage furrow; and midbody. Implicated in progressive familial intrahepatic cholestasis. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030800
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030800
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030800
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: The condition involves sequelae of cholestasis, and medical management (with ursodeoxycholic acid) has been described as beneficial; Liver transplant has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZFYVE19 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001077268.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 13 | ||||
| missense | 1 | 73 | 12 | 86 | ||
| nonsense | 5 | 1 | 6 | |||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 6 | 3 | 76 | 25 | 0 | 110 |
Highest pathogenic variant AF is 0.000029737897
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001070736.1 | 11 | MANE Select | |
| Ensembl | ENSP00000347498.4 | 11 | MANE Select | |
| RefSeq | NP_001245349.1 | 10 | Standard | |
| RefSeq | NP_001245350.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- abscission
- negative regulation of cytokinesis
- mitotic cytokinesis checkpoint
- cell division
Molecular Function
- protein binding
- phosphatidylinositol-3-phosphate binding
- metal ion binding
Cellular Component
- cytoplasm
- centrosome
- midbody
- cleavage furrow
- Flemming body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000355341
- Coding exons
- 11
- Length
- 7484
- Individuals with no LoFs
- 124740
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 84
- Defined
- 124824
- p
- 0.000337
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.445 | 251 | 272 | 0.924 | 0.0000153 | 2989 |
| Missense (PolyPhen) | 62 | 73.807 | 0.84003 | 883 | ||
| Synonymous | 0.135 | 102 | 104 | 0.983 | 0.00000546 | 943 |
| Loss of Function | 0.942 | 24 | 29.5 | 0.813 | 0.00000171 | 281 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000064 | rare |
| Latino/Admixed American | 0.00032 | 0.00032 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0020 | 0.0020 | notable |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00024 | 0.00024 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission. {ECO:0000269|PubMed:24814515}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ZFYVE19 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with KMT2A/MLL1 (PubMed:12618766). {ECO:0000269|PubMed:12618766}.;
Intolerance Scores
- LoFtool
- 0.737
- RVIS EVS
- 1.62
- RVIS percentile EVS
- 96.01
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.465
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |